Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31 Mar 2026 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|
| Revenue | 45M | 36M | 33M | 32M | 34M | 28M |
| Gross profit | 19M | 18M | 15M | 14M | 4M | 6M |
| Research and development | 1M | 1M | 929,000 | 793,000 | 1M | 962,000 |
| Selling, general and administrative | 12M | 9M | 11M | 9M | 13M | 13M |
| Operating expenses | 21M | 19M | 20M | 18M | 37M | 22M |
| Operating income | −2M | −503,000 | −5M | −4M | −34M | −16M |
| Pre-tax income | 18M | 27M | −39M | 7M | 5M | −11M |
| Income tax | 2M | −1M | −525,000 | −455,000 | −3M | −2M |
| Net income | 14M | 26M | −38M | 8M | 8M | −9M |
| Earnings per share | 0.04 | 0.07 | −0.10 | 0.02 | 0.02 | −0.02 |
| Earnings per share, diluted | 0.04 | 0.07 | −0.10 | 0.02 | 0.02 | −0.02 |
| Metric | 31 Mar 2026 | 31 Dec 2025 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 31 Dec 2024 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 822M | 792M | 784M | 794M | 798M | 859M | 862M | 848M |
| Short-term investments | 0 | 40M | 40M |
| Metric | 31 Mar 2026 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|
| Operating cash flow | 11M | — | — | −2M | — | — |
| Depreciation and amortisation | 4M | 354,000 | 867,000 | 3M |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 40M |
| 40M |
| 0 |
| 0 |
| 0 |
| Receivables | 33M | 34M | 27M | 27M | 19M | 15M | 20M | 16M |
| Inventory | 49M | 47M | 48M | 42M | 35M | 33M | 47M | 29M |
| Current assets | 928M | 944M | 922M | 927M | 919M | 936M | 959M | 935M |
| Property, plant and equipment | 142M | 146M | 146M | 150M | 139M | 133M | 163M | 37M |
| Goodwill | 65M | 66M | 65M | 67M | 63M | 63M | 38M | 1M |
| Total assets | 1.17B | 1.20B | 1.18B | 1.18B | 1.15B | 1.17B | 1.18B | 1.09B |
| Current liabilities | 42M | 48M | 41M | 38M | 33M | 50M | 40M | 33M |
| Total liabilities | 48M | 54M | 46M | 45M | 39M | 55M | 53M | 35M |
| Equity | 1.07B | 1.09B | 1.08B | 1.13B | 1.11B | 1.06B | 1.13B | 1.06B |
| Shares outstanding | 376M | 382M | 383M | 384M | 385M | 383M | 382M | 382M |
| Shares issued | 376M | 382M | 383M | 384M | 385M | 383M | 382M | 382M |
| 1M |
| 1M |
| Share-based compensation | 1M | — | — | 2M | — | — |
| Capital expenditure | 2M | — | — | 15M | — | — |
| Investing cash flow | 38M | — | — | −55M | — | — |
| Share buybacks | 17M | — | — | 0 | — | — |
| Financing cash flow | −18M | — | — | −3M | — | — |